Companies: 10,795·Total market cap: $144.5T

PMGC Holdings Inc.

PMGC Holdings Inc.

ELABNASDAQHealthcare● Active

$1.59

+$0.05(+3.25%)

Market Cap$3079466

P/E Ratio—

52W High$309.89474

52W Low$1.54

Avg Volume7.7M

Open$1.61

Beta-0.28

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

PMGC Holdings Inc.（ELAB）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · ELAB · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-218.85Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)$1.3MFull revenue history

Dividend Yield不分红Dividend history

Shares Outstanding20,352Shares outstanding history

Next EarningsTBAEarnings history

探索 PMGC Holdings Inc. 数据

分析师预测—

股息不分红

营收$590084-76.08%

盈利EPS $-378.74+94.25%

财务快照

FY 2025Revenue$590084.00▼ 76.08% YoY

202320242025

FY 2025Net Income-$7.7M▼ 23.41% YoY

202320242025

FY 2025EPS$-378.74▲ +94.25% YoY

202320242025

TTM:Revenue: $1.3MNet Income: -$11.1MEPS: $-218.85View income statement →

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

PMGC Holdings Inc.

$1.59+3.25%$3.1M #2

Avenue Therapeutics, Inc.

$0.31-12.06%$1.0M #3

BriaCell Therapeutics Corp. Warrant

$0.08+0.75%$150,888 #4

Dermata Therapeutics, Inc.

$1.21+2.54%$824,684 #5

Moolec Science S.A.

$7.14-4.42%$5.2M #6

$3.16+7.85%$1.4M

股票表现

1D+3.25%

1W-4.79%

1M-19.70%

3M-64.19%

YTD-98.88%

1Y-99.82%

5Y-100.00%

关于 PMGC Holdings Inc.

CEOGraydon Bensler

IPO DateNov 21, 2023

Employees2

CountryUS

Websitepmgcholdings.com

PMGC Holdings Inc. functions as a biopharmaceutical firm, primarily dedicated to sourcing and advancing innovative aesthetic and therapeutic solutions. Its flagship product, EL-22, is a pioneering eng…

Biotechnology HealthcareNASDAQUS

关于股票概览与关键数据

PMGC Holdings Inc.（ELAB）是 Biotechnology 行业的 Healthcare 类公司，于 Nov 21, 2023 在 NASDAQ 上市。截至最近交易日，ELAB 股价为 $1.59，市值约为 $3.1M。过去12个月累计回报 -99.82%，年初至今回报 -98.88%。

2025 财年 PMGC Holdings Inc. 营收 $590084.00。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。

常见问题

截至最近一个交易日，PMGC Holdings Inc.（ELAB）股价为 $1.59，在 NASDAQ 上市，52周区间为 $1.54 – $309.89。

ELAB 最新股价ELAB quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议